HI SB1213 | 2023 | Regular Session

Note: Carry Foward to future SB1213

Status

Spectrum: Partisan Bill (Democrat 1-0)
Status: Introduced on January 25 2023 - 25% progression, died in committee
Action: 2023-01-27 - Referred to HHS/EDU, JDC.
Pending: Senate Health and Human Services Committee
Text: Latest bill text (Introduced) [HTML]

Summary

Requires all private schools to develop and implement comprehensive action plans for the management of anaphylaxis in their respective schools, including administration of auto-injectable epinephrine. Establishes certain immunity from liability for designated private school employees and agents who administer auto-injectable epinephrine during emergencies.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Relating To Education.

Sponsors


History

DateChamberAction
2023-01-27SenateReferred to HHS/EDU, JDC.
2023-01-25SenatePassed First Reading.
2023-01-25SenateIntroduced.

Same As/Similar To

SB1213 (Carry Over) 2023-01-27 - Referred to HHS/EDU, JDC.
HB183 (Same As) 2023-01-25 - Referred to HLT, EDN, JHA, referral sheet 1

Subjects


Hawaii State Sources


Bill Comments

feedback